NIKKEI 225
38,485.26 -349.84 (-0.90%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.21 -0.17 (-0.22%) GOLD FUTURES
2,323.00 -1.20 (-0.05%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
50,115.83 -735.93 (-1.45%)
Insmed Incorporated (0JAV.L)
| Previous close | 25.71 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 1,364 |
| Market cap | 23.5M |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Insmed To Present at the BofA Securities Health Care Conference 2024
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present in a fireside chat at the BofA Securities Health Care Conference 2024 in Las Vegas, NV, on Tuesday, May 14, 2024 at 2:20 p.m. PT (5:20 p.m. ET).
- PR Newswire
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to 63 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.
- PR Newswire
Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its first-quarter 2024 financial results on Thursday, May 9, 2024.
